226 related articles for article (PubMed ID: 3659256)
1. Metastatic adeno or undifferentiated carcinoma from an unknown primary site--natural history and guidelines for identification of treatable subsets.
Kirsten F; Chi CH; Leary JA; Ng AB; Hedley DW; Tattersall MH
Q J Med; 1987 Feb; 62(238):143-61. PubMed ID: 3659256
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
3. The management of patients with adenocarcinoma and poorly differentiated carcinoma of unknown primary site.
Greco FA; Hainsworth JD
Semin Oncol; 1989 Aug; 16(4 Suppl 6):116-22. PubMed ID: 2669133
[TBL] [Abstract][Full Text] [Related]
4. [Metastatic carcinoma of unknown origin].
Fizazi K; Culine S
Bull Cancer; 1998 Jul; 85(7):609-17. PubMed ID: 9752267
[TBL] [Abstract][Full Text] [Related]
5. Malignancies of undetermined primary origin.
Bitran JD; Ultmann JE
Dis Mon; 1992 Apr; 38(4):213-60. PubMed ID: 1547698
[TBL] [Abstract][Full Text] [Related]
6. Metastasis of unknown origin.
Perchalski JE; Hall KL; Dewar MA
Prim Care; 1992 Dec; 19(4):747-57. PubMed ID: 1465485
[TBL] [Abstract][Full Text] [Related]
7. [Cancers of unknown origin: 311 cases].
Lortholary A; Abadie-Lacourtoisie S; Guérin O; Mege M; Rauglaudre GD; Gamelin E
Bull Cancer; 2001 Jun; 88(6):619-27. PubMed ID: 11459709
[TBL] [Abstract][Full Text] [Related]
8. Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary tumor site.
Hainsworth JD; Greco FA
Semin Oncol; 1993 Jun; 20(3):279-86. PubMed ID: 8503024
[TBL] [Abstract][Full Text] [Related]
9. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
10. The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma.
Schapira DV; Jarrett AR
Arch Intern Med; 1995 Oct; 155(19):2050-4. PubMed ID: 7575063
[TBL] [Abstract][Full Text] [Related]
11. Adenocarcinoma of unknown primary site.
Jubelirer SJ
W V Med J; 1989 Jan; 85(1):9-12. PubMed ID: 2913715
[TBL] [Abstract][Full Text] [Related]
12. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study.
Seve P; Sawyer M; Hanson J; Broussolle C; Dumontet C; Mackey JR
Cancer; 2006 May; 106(9):2058-66. PubMed ID: 16583433
[TBL] [Abstract][Full Text] [Related]
13. [Unknown primary cancer].
Furue H
Gan To Kagaku Ryoho; 1998 Jan; 25(1):1-6. PubMed ID: 9464322
[TBL] [Abstract][Full Text] [Related]
14. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
16. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
18. [Liver metastases with unknown primary site].
Drug VL; Popa I; Cijevschi C; Miron L; Mitrică D; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):298-305. PubMed ID: 14755931
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and treatment of 39 patients with cervical lymph node metastases of squamous cell carcinoma of unknown primary origin, referred to Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1979-98].
Klop WM; Balm AJ; Keus RB; Hilgers FJ; Tan IB
Ned Tijdschr Geneeskd; 2000 Jul; 144(28):1355-60. PubMed ID: 10923158
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]